The role of salvage surgery in the treatment of a gefitinib-resistant non-small cell lung cancer patient: a case report

被引：7

作者：

Zang, Jing ^{[1
,2
]}

Horinouchi, Hidehito ^{[3
]}

Hanaoka, Jun ^{[4
]}

Funai, Kazuhito ^{[5
]}

Sakakura, Noriaki ^{[6
]}

Liao, Hu ^{[7
]}

机构：

[1] Sichuan Univ, West China Univ Hosp 2, Dept Ultrasound, West China Womens & Childrens Hosp, Chengdu, Peoples R China

[2] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China

[3] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo, Japan

[4] Shiga Univ Med Sci, Dept Surg, Div Gen Thorac Surg, Otsu, Shiga, Japan

[5] Hamamatsu Univ Sch Med, Dept Surg 1, Higashi Ku, Hamamatsu, Shizuoka, Japan

[6] Aichi Canc Ctr Hosp, Dept Thorac Surg, Chikusa Ku, Nagoya, Aichi, Japan

[7] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu, Peoples R China

来源：

JOURNAL OF THORACIC DISEASE | 2021年 / 13卷 / 07期

关键词：

RECEPTOR EGFR MUTATION; OPEN-LABEL; 1ST-LINE ERLOTINIB; CHEMOTHERAPY; MULTICENTER; AFATINIB;

D O I：

10.21037/jtd-21-171

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：4554 / 4559

页数：6

共 50 条

[1] Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
Sin, Thomas K.
Wang, Fengfeng
Meng, Fei
Wong, S. C. Cesar
Cho, William C. S.
Siu, Parco M.
Chan, Lawrence W. C.
Yung, Benjamin Y. M.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
[2] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
Makoto Sudo
Tan Min Chin
Seiichi Mori
Ngan B. Doan
Jonathan W. Said
Makoto Akashi
H. Phillip Koeffler
Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
[3] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
Sudo, Makoto
Chin, Tan Min
Mori, Seiichi
Doan, Ngan B.
Said, Jonathan W.
Akashi, Makoto
Koeffler, H. Phillip
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
[4] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
Suzuki, Atsuo
Kuzumaki, Naoko
Hosoya, Takahiro
Narita, Michiko
Tsukiji, Kozue
Suzuki, Masami
Uezono, Yasuhito
Morita, Hiroshi
Suzuki, Tsutomu
Narita, Minoru
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
[5] Dominant FGF Autocrine Signaling in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells
Heasley, Lynn E.
Marek, Lindsay
Fritzsche, Alexa
Helton, Wallace R.
Nemenoff, Raphael A.
McDermott, Lee A.
Helfrich, Barbara
Bunn, Paul A.
FASEB JOURNAL, 2008, 22
[6] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
Sha, Huanhuan
Dong, Shuchen
Yu, Chen
Zou, Renrui
Zhu, Yue
Lu, Ya
Zhang, Junying
Cao, Haixia
Chen, Dan
Wu, Jianzhong
Feng, Jifeng
JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
[7] Role of adenosine A2a receptors in the growth control of a gefitinib-resistant non-small cell lung cancer cell growth
Noguchi, Maki
Kuzumaki, Naoko
Nagasawa, Atsumi
Narita, Michiko
Narita, Minoru
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 197P - 197P
[8] Salvage surgery for advanced non-small cell lung cancer after response to gefitinib
Hishida, Tomoyuki
Nagai, Kanji
Mitsudomi, Tetsuya
Yokoi, Kohei
Kondo, Haruhiko
Horinouchi, Hirohisa
Akiyama, Hirohiko
Nagayasu, Takeshi
Tsuboi, Masahiro
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (05): : E69 - E71
[9] Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
Chen, Mu-Tong
Li, Bai-Zhi
Zhang, En-Pu
Zheng, Qing
MEDICINE, 2023, 102 (40) : E35086
[10] The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
Mohiuddin, Md
Kasahara, Kazuo
CANCER GENOMICS & PROTEOMICS, 2021, 18 (05) : 661 - 673

← 1 2 3 4 5 →